SEC Form 4 · accession 0001209191-18-044402
NovoCure Ltd · NVCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Wilhelmus Cm Groenhuysen
Officer — Chief Financial Officer
Period of report
Jul 27, 2018
Accepted (ET)
Jul 30, 2018 · 4:39 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001645113
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Jul 27, 2018 | S | 3,710 | $33.86 | D | 175,602 | D | |
| Ordinary SharesF2 | Jul 27, 2018 | S | 17,437 | $34.44 | D | 158,165 | D | |
| Ordinary SharesF3 | Jul 27, 2018 | S | 34,385 | $35.20 | D | 123,780 | D | |
| Ordinary SharesF4 | Jul 27, 2018 | S | 6,095 | $36.60 | D | 117,685 | D | |
| Ordinary SharesF5 | Jul 27, 2018 | S | 1,100 | $37.05 | D | 116,585 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On July 27, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen, Mr. Groenhuysen sold 3,710 shares in multiple trades at prices ranging from $33.70 to $33.95. The price reported above reflects the weighted average sale price. Mr. Groenhuysen hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
- F2On July 27, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen, Mr. Groenhuysen sold 17,437 shares in multiple trades at prices ranging from $34.00 to $34.98. The price reported above reflects the weighted average sale price. Mr. Groenhuysen hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
- F3On July 27, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen, Mr. Groenhuysen sold 34,385 shares in multiple trades at prices ranging from $35.00 to $35.90. The price reported above reflects the weighted average sale price. Mr. Groenhuysen hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
- F4On July 27, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen, Mr. Groenhuysen sold 6,095 shares in multiple trades at prices ranging from $36.00 to $36.95. The price reported above reflects the weighted average sale price. Mr. Groenhuysen hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
- F5On July 27, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen, Mr. Groenhuysen sold 1,100 shares in multiple trades at prices ranging from $37.00 to $37.10. The price reported above reflects the weighted average sale price. Mr. Groenhuysen hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.